C-MER Medical Holdings Limited (stock code: 03309) has disclosed a share repurchase on 13 February 2026. The company repurchased 0.15 million shares on the Hong Kong Stock Exchange at prices ranging between HKD 1.45 and HKD 1.47 per share, totaling HKD 218,760. These repurchased shares are held as treasury shares, causing the treasury share balance to increase from 19.99 million shares to 20.14 million shares.

The overall issued share capital remains 1.23 billion shares. Of these, 1.21 billion shares are issued and outstanding (excluding treasury shares), down by 0.15 million from the previous balance. No shares have been canceled, and the current repurchase mandate, granted on 19 May 2025, authorized up to 125.56 million shares for repurchase. The shares repurchased to date represent 0.0119% of the number of issued shares (excluding treasury shares) as of the mandate date.